REZOLUTE, INC. Operating Expenses
REZOLUTE, INC. (RZLT) reported Operating Expenses of $82.97 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-09-24
- REZOLUTE, INC. operating expenses for the quarter ending 2026-06-30 was $21.56M, a 16.59% decline year-over-year.
- REZOLUTE, INC. operating expenses for the quarter ending 2026-03-31 was $17.37M, a 13.27% decline year-over-year.
- REZOLUTE, INC. operating expenses for the quarter ending 2025-12-31 was $24.22M, a 41.81% increase year-over-year.
- REZOLUTE, INC. operating expenses for the quarter ending 2025-09-30 was $19.82M, a 16.98% increase year-over-year.
- REZOLUTE, INC. operating expenses for fiscal 2026 was $82.97M, a 3.85% increase from fiscal 2025.
- REZOLUTE, INC. operating expenses for fiscal 2025 was $79.89M, a 13.45% increase from fiscal 2024.
- REZOLUTE, INC. operating expenses for fiscal 2024 was $70.42M, a 25.78% increase from fiscal 2023.
- REZOLUTE, INC. operating expenses for fiscal 2023 was $55.99M, a 33.81% increase from fiscal 2022.
| Period end | Operating Expenses 2 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 5 month | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 11 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 14 month | Operating Expenses 17 month | Operating Expenses 20 month | Operating Expenses 26 month | Operating Expenses 29 month | Operating Expenses 36 month | Operating Expenses 39 month | Operating Expenses 42 month | Operating Expenses 45 month | Operating Expenses 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24 | $38.93M derived: sum of 2 quarters · filed 2026-09-24 | $63.15M derived: sum of 3 quarters · filed 2026-09-24 | $82.97M 10-K · filed 2026-09-24 | ||||||||||||||||||
| 2026-03-31 | $17.37M 10-Q · filed 2026-05-12 | $41.59M derived: sum of 2 quarters · filed 2026-05-12 | $61.40M 10-Q · filed 2026-05-12 | $87.25M derived: sum of 4 quarters · filed 2026-09-24 | ||||||||||||||||||
| 2025-12-31 | $24.22M 10-Q · filed 2026-02-12 | $44.04M 10-Q · filed 2026-02-12 | $69.89M derived: sum of 3 quarters · filed 2026-09-24 | $89.91M derived: sum of 4 quarters · filed 2026-09-24 | ||||||||||||||||||
| 2025-09-30 | $19.82M 10-Q · filed 2025-11-06 | $45.67M derived: sum of 2 quarters · filed 2026-09-24 | $65.69M derived: sum of 3 quarters · filed 2026-09-24 | $82.77M derived: sum of 4 quarters · filed 2026-09-24 | ||||||||||||||||||
| 2025-06-30 | $25.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24 | $45.87M derived: sum of 2 quarters · filed 2026-09-24 | $62.95M derived: sum of 3 quarters · filed 2026-09-24 | $79.89M 10-K · filed 2026-09-24 | ||||||||||||||||||
| 2025-03-31 | $20.02M 10-Q · filed 2026-05-12 | $37.10M derived: sum of 2 quarters · filed 2026-05-12 | $54.04M 10-Q · filed 2026-05-12 | $77.15M derived: sum of 4 quarters · filed 2026-05-12 | ||||||||||||||||||
| 2024-12-31 | $17.08M 10-Q · filed 2026-02-12 | $34.02M 10-Q · filed 2026-02-12 | $57.12M derived: sum of 3 quarters · filed 2026-02-12 | $73.34M derived: sum of 4 quarters · filed 2026-02-12 | ||||||||||||||||||
| 2024-09-30 | $16.94M 10-Q · filed 2025-11-06 | $40.04M derived: sum of 2 quarters · filed 2025-11-06 | $56.26M derived: sum of 3 quarters · filed 2025-11-06 | $71.45M derived: sum of 4 quarters · filed 2025-11-06 | ||||||||||||||||||
| 2024-06-30 | $23.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | $39.31M derived: sum of 2 quarters · filed 2025-09-17 | $54.51M derived: sum of 3 quarters · filed 2025-09-17 | $70.42M 10-K · filed 2025-09-17 | ||||||||||||||||||
| 2024-03-31 | $16.21M 10-Q · filed 2025-05-13 | $31.41M derived: sum of 2 quarters · filed 2025-05-13 | $47.32M 10-Q · filed 2025-05-13 | $61.56M derived: sum of 4 quarters · filed 2025-05-13 | ||||||||||||||||||
| 2023-12-31 | $15.19M 10-Q · filed 2025-02-12 | $31.11M 10-Q · filed 2025-02-12 | $45.35M derived: sum of 3 quarters · filed 2025-02-12 | $62.49M derived: sum of 4 quarters · filed 2025-02-12 | ||||||||||||||||||
| 2023-09-30 | $15.91M 10-Q · filed 2024-11-07 | $30.15M derived: sum of 2 quarters · filed 2024-11-07 | $47.29M derived: sum of 3 quarters · filed 2024-11-07 | $61.69M derived: sum of 4 quarters · filed 2024-11-07 | ||||||||||||||||||
| 2023-06-30 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $31.38M derived: sum of 2 quarters · filed 2024-09-19 | $45.77M derived: sum of 3 quarters · filed 2024-09-19 | $55.99M 10-K · filed 2024-09-19 | ||||||||||||||||||
| 2023-03-31 | $17.14M 10-Q · filed 2024-05-15 | $31.53M derived: sum of 2 quarters · filed 2024-05-15 | $41.75M 10-Q · filed 2024-05-15 | $53.05M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||||||||
| 2022-12-31 | $14.39M 10-Q · filed 2024-02-13 | $24.61M 10-Q · filed 2024-02-13 | $35.91M derived: sum of 3 quarters · filed 2024-02-13 | $46.66M derived: sum of 4 quarters · filed 2024-02-13 | ||||||||||||||||||
| 2022-09-30 | $10.22M 10-Q · filed 2023-11-13 | $21.52M derived: sum of 2 quarters · filed 2023-11-13 | $32.27M derived: sum of 3 quarters · filed 2023-11-13 | $44.42M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||||||||
| 2022-06-30 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14 | $22.05M derived: sum of 2 quarters · filed 2023-09-14 | $34.20M derived: sum of 3 quarters · filed 2023-09-14 | $41.84M 10-K · filed 2023-09-14 | ||||||||||||||||||
| 2022-03-31 | $10.75M 10-Q · filed 2023-05-11 | $22.90M derived: sum of 2 quarters · filed 2023-05-11 | $30.54M 10-Q · filed 2023-05-11 | $37.18M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||||||||||||
| 2021-12-31 | $12.15M 10-Q · filed 2023-02-10 | $19.79M 10-Q · filed 2023-02-10 | $26.43M derived: sum of 3 quarters · filed 2023-02-10 | $31.91M derived: sum of 4 quarters · filed 2023-02-10 | ||||||||||||||||||
| 2021-09-30 | $7.64M 10-Q · filed 2022-11-09 | $14.28M derived: sum of 2 quarters · filed 2022-11-09 | $19.76M derived: sum of 3 quarters · filed 2022-11-09 | $26.91M derived: sum of 4 quarters · filed 2022-11-09 | ||||||||||||||||||
| 2021-06-30 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15 | $12.12M derived: sum of 2 quarters · filed 2022-09-15 | $19.27M derived: sum of 3 quarters · filed 2022-09-15 | $22.89M 10-K · filed 2022-09-15 | ||||||||||||||||||
| 2021-03-31 | $5.48M 10-Q · filed 2022-05-12 | $12.63M derived: sum of 2 quarters · filed 2022-05-12 | $16.26M 10-Q · filed 2022-05-12 | $19.81M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||||||
| 2020-12-31 | $7.15M 10-Q · filed 2022-02-09 | $10.78M 10-Q · filed 2022-02-09 | $14.33M derived: sum of 3 quarters · filed 2022-02-09 | $19.40M derived: sum of 4 quarters · filed 2022-02-09 | ||||||||||||||||||
| 2020-09-30 | $3.62M 10-Q · filed 2021-11-12 | $7.17M derived: sum of 2 quarters · filed 2021-11-12 | $12.24M derived: sum of 3 quarters · filed 2021-11-12 | $18.96M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||||||||||
| 2020-06-30 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-15 | $8.62M derived: sum of 2 quarters · filed 2021-09-15 | $15.34M derived: sum of 3 quarters · filed 2021-09-15 | $20.52M 10-K · filed 2021-09-15 | ||||||||||||||||||
| 2020-03-31 | $5.07M 10-Q · filed 2021-05-17 | $11.79M derived: sum of 2 quarters · filed 2021-05-17 | $16.97M 10-Q · filed 2021-05-17 | $20.15M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||||||||
| 2019-12-31 | $6.72M 10-Q · filed 2021-02-10 | $11.90M 10-Q · filed 2021-02-10 | $15.08M derived: sum of 3 quarters · filed 2021-02-10 | $32.12M derived: sum of 4 quarters · filed 2021-02-10 | ||||||||||||||||||
| 2019-09-30 | $5.18M 10-Q · filed 2020-11-12 | $8.36M derived: sum of 2 quarters · filed 2020-11-12 | $25.40M derived: sum of 3 quarters · filed 2020-11-12 | $28.56M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||||||||||||
| 2019-06-30 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $20.22M derived: sum of 2 quarters · filed 2020-10-13 | $23.38M derived: sum of 3 quarters · filed 2020-10-13 | $25.94M 10-K · filed 2020-10-13 | ||||||||||||||||||
| 2019-03-31 | $17.04M 10-Q · filed 2020-05-14 | $20.20M derived: sum of 2 quarters · filed 2020-05-14 | $22.76M 10-Q · filed 2020-05-14 | $34.07M derived: sum of 4 quarters · filed 2020-05-14 | ||||||||||||||||||
| 2018-12-31 | $3.16M 10-Q · filed 2020-02-12 | $5.72M 10-Q · filed 2020-02-12 | $17.04M derived: sum of 3 quarters · filed 2020-02-12 | $21.99M derived: sum of 4 quarters · filed 2020-02-12 | ||||||||||||||||||
| 2018-09-30 | $2.56M 10-Q · filed 2019-11-14 | $2.56M 10-Q · filed 2018-12-14 | $13.87M derived: sum of 2 quarters · filed 2019-11-14 | $18.83M derived: sum of 3 quarters · filed 2019-11-14 | $24.58M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||||||
| 2018-06-30 | $11.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10 | $16.27M derived: sum of 2 quarters · filed 2019-09-10 | $22.02M derived: sum of 3 quarters · filed 2019-09-10 | $28.73M 10-K · filed 2019-09-10 | $28.73M 10-K · filed 2018-10-15 | |||||||||||||||||
| 2018-03-31 | $4.95M 10-Q · filed 2018-05-15 | $10.70M derived: sum of 2 quarters · filed 2018-05-15 | $17.42M 10-Q · filed 2018-05-15 | $23.64M derived: sum of 4 quarters · filed 2018-12-14 | ||||||||||||||||||
| 2017-12-31 | $5.75M 10-Q · filed 2018-02-14 | $12.47M 10-Q · filed 2018-02-14 | $18.69M derived: sum of 3 quarters · filed 2018-12-14 | $24.08M derived: sum of 4 quarters · filed 2018-12-14 | ||||||||||||||||||
| 2017-09-30 | $6.72M 10-Q · filed 2018-12-14 | $12.94M derived: sum of 2 quarters · filed 2018-12-14 | $18.33M derived: sum of 3 quarters · filed 2018-12-14 | $23.22M derived: sum of 4 quarters · filed 2018-12-14 | ||||||||||||||||||
| 2017-06-30 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $11.61M derived: sum of 2 quarters · filed 2018-10-15 | $16.50M derived: sum of 3 quarters · filed 2018-10-15 | $20.32M 10-K · filed 2018-10-15 | ||||||||||||||||||
| 2017-03-31 | $5.39M 10-Q · filed 2018-05-15 | $10.28M derived: sum of 2 quarters · filed 2018-05-15 | $14.10M 10-Q · filed 2018-05-15 | $17.97M derived: sum of 4 quarters · filed 2018-05-15 | ||||||||||||||||||
| 2016-12-31 | $4.89M 10-Q · filed 2018-02-14 | $8.71M 10-Q · filed 2018-02-14 | $12.58M derived: sum of 3 quarters · filed 2018-02-14 | $16.30M derived: sum of 4 quarters · filed 2018-02-14 | ||||||||||||||||||
| 2016-09-30 | $3.82M 10-Q · filed 2017-11-14 | $7.69M derived: sum of 2 quarters · filed 2017-11-14 | $11.41M derived: sum of 3 quarters · filed 2017-11-14 | $15.48M derived: sum of 4 quarters · filed 2017-11-14 | ||||||||||||||||||
| 2016-06-30 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-22 | $7.59M derived: sum of 2 quarters · filed 2017-09-22 | $11.65M derived: sum of 3 quarters · filed 2017-09-22 | $14.95M 10-K · filed 2017-09-22 | ||||||||||||||||||
| 2016-03-31 | $3.72M 10-Q · filed 2017-05-15 | $7.78M derived: sum of 2 quarters · filed 2017-05-15 | $11.08M 10-Q · filed 2017-05-15 | $14.18M derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||||||||
| 2015-12-31 | $4.07M 10-Q · filed 2017-02-02 | $7.37M 10-Q · filed 2017-02-02 | $10.46M derived: sum of 3 quarters · filed 2017-02-02 | $12.76M derived: sum of 4 quarters · filed 2017-02-02 | ||||||||||||||||||
| 2015-09-30 | $3.30M 10-Q · filed 2016-11-14 | $6.39M derived: sum of 2 quarters · filed 2016-11-14 | $8.69M derived: sum of 3 quarters · filed 2016-11-14 | $11.76M derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||||||||
| 2015-06-30 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $5.39M derived: sum of 2 quarters · filed 2016-09-28 | $8.46M derived: sum of 3 quarters · filed 2016-09-28 | $10.70M 10-K · filed 2016-09-28 | ||||||||||||||||||
| 2015-03-31 | $2.30M 10-Q · filed 2016-05-16 | $5.37M derived: sum of 2 quarters · filed 2016-05-16 | $7.60M 10-Q · filed 2016-05-16 | $9.83M derived: sum of 4 quarters · filed 2016-05-16 | ||||||||||||||||||
| 2014-12-31 | $3.07M 10-Q · filed 2016-02-16 | $5.30M 10-Q · filed 2016-02-16 | $7.53M derived: sum of 3 quarters · filed 2016-02-16 | $9.13M derived: sum of 4 quarters · filed 2016-02-16 | ||||||||||||||||||
| 2014-09-30 | $2.24M 10-Q · filed 2015-11-16 | $4.46M derived: sum of 2 quarters · filed 2015-11-16 | $6.06M derived: sum of 3 quarters · filed 2015-11-16 | $6.71M derived: sum of 4 quarters · filed 2015-11-16 | ||||||||||||||||||
| 2014-06-30 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $3.83M derived: sum of 2 quarters · filed 2015-09-28 | $4.48M derived: sum of 3 quarters · filed 2015-09-28 | $5.18M 10-K · filed 2015-09-28 | ||||||||||||||||||
| 2014-03-31 | $1.60M 10-Q · filed 2015-05-15 | $2.25M derived: sum of 2 quarters · filed 2015-05-15 | $2.95M 10-Q · filed 2015-05-15 | $3.96M derived: sum of 4 quarters · filed 2015-05-15 | $9.91M 10-Q · filed 2014-05-14 | |||||||||||||||||
| 2013-12-31 | $650.12K 10-Q · filed 2015-02-17 | $1.35M 10-Q · filed 2015-02-17 | $2.37M derived: sum of 3 quarters · filed 2015-02-17 | $6.42M derived: sum of 4 quarters · filed 2015-02-17 | $8.32M 10-Q · filed 2014-02-13 | |||||||||||||||||
| 2013-09-30 | $700.90K 10-Q · filed 2014-11-12 | $1.72M derived: sum of 2 quarters · filed 2014-11-12 | $5.77M derived: sum of 3 quarters · filed 2014-11-12 | $6.27M derived: sum of 4 quarters · filed 2014-11-12 | $7.67M 10-Q · filed 2013-11-12 | |||||||||||||||||
| 2013-06-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | $5.07M derived: sum of 2 quarters · filed 2014-09-30 | $5.57M derived: sum of 3 quarters · filed 2014-09-30 | $6.11M 10-K · filed 2014-09-30 | $6.97M 10-K · filed 2013-09-11 | |||||||||||||||||
| 2013-03-31 | $4.05M 10-Q · filed 2014-05-14 | $4.55M derived: sum of 2 quarters · filed 2014-05-14 | $5.09M 10-Q · filed 2014-05-14 | $5.23M derived: sum of 4 quarters · filed 2014-05-14 | $5.95M 10-Q · filed 2013-05-15 | |||||||||||||||||
| 2012-12-31 | $500.06K 10-Q · filed 2014-02-13 | $9.31K 10-Q · filed 2013-02-14 | $1.04M 10-Q · filed 2014-02-13 | $19.06K 10-Q · filed 2013-02-14 | $1.18M derived: sum of 3 quarters · filed 2014-02-13 | $1.27M derived: sum of 4 quarters · filed 2014-02-13 | $110.27K 10-Q · filed 2013-02-14 | |||||||||||||||
| 2012-09-30 | $542.88K 10-Q · filed 2013-11-12 | $9.75K 10-Q · filed 2012-11-19 | $676.19K derived: sum of 2 quarters · filed 2013-11-12 | $770.78K derived: sum of 3 quarters · filed 2013-11-12 | $778.78K derived: sum of 4 quarters · filed 2013-11-12 | $100.96K 10-Q · filed 2012-11-19 | ||||||||||||||||
| 2012-06-30 | $133.31K derived: 10-K 6 month − 10-Q 3 month · filed 2013-09-11 | $227.90K 10-K · filed 2013-09-11 | $235.90K derived: sum of 3 quarters · filed 2013-09-11 | $91.21K 10-K/A · filed 2012-11-09 | $49.29K 10-K/A · filed 2012-11-09 | |||||||||||||||||
| 2012-03-31 | $94.60K 10-Q · filed 2013-05-15 | $9.95K 10-Q · filed 2012-05-15 | $102.59K derived: sum of 2 quarters · filed 2013-05-15 | $356.53K 10-Q · filed 2013-05-15 | $25.34K 10-Q · filed 2012-05-15 | $67.26K 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2011-12-31 | $8.00K 10-Q · filed 2013-02-14 | $15.39K 10-Q · filed 2013-02-14 | $392.98K 10-K · filed 2013-09-11 | $57.32K 10-Q · filed 2012-02-14 | ||||||||||||||||||
| 2011-09-30 | $7.39K 10-Q · filed 2012-11-19 | $49.32K 10-Q/A · filed 2011-12-13 | ||||||||||||||||||||
| 2011-06-30 | $41.93K 10-K/A · filed 2012-11-09 | |||||||||||||||||||||
| 2011-03-31 | $24.41K 10-Q · filed 2012-05-15 | $26.16K derived: sum of 2 quarters · filed 2012-05-15 | $26.75K 10-Q · filed 2012-05-15 | |||||||||||||||||||
| 2010-12-31 | $1.75K 10-Q · filed 2012-02-14 | $26.75K 10-Q · filed 2012-02-14 | ||||||||||||||||||||
| 2010-09-30 | $25.00K 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |